Cryptome completes acquisition of HealthLinx
The all-scrip acquisition has been accompanied by a capital raising of $2 million, which provides a strong funding base for the business, alongside revenue to be generated by the previously announced Dairy Australia contract. The merged entity will be known as HealthLinx Limited (HealthLinx). A new ASX code will be allocated and advised shortly.
Other news from the department business & finance
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.